In this video, Taron, a scientist at Hardy Nutritionals®, discusses the "Possible Limiting Factors" section of the Daily Essential Nutrients Clinical Reference Guide, which regards the management of psychiatric medications.

University of Canterbury researchers have again demonstrated broad-spectrum micronutrients to be a viable alternative to conventional medication for anxiety and depression. In Christchurch, New Zealand, university researchers are attempting to address "common but serious psychiatric problems" in the community.

In all, there are now over 100 medical journal publications backing the use of micronutrients for psychiatric disorders spanning a myriad of diagnoses.  Each of these studies has been independently funded, and carried out by university researchers.

"We have literally tried everything under the sun except for prescription drugs to help our son with ADHD & ODD. This includes several extensive therapies both of the holistic and traditional varieties as well as many, many supplements."

I was diagnosed late Nov 2017, & med-free by April 2018. Now it’s been four months med-free, going on five. I’m glad I was able to make the switch to supplements. I’m thriving thanks to Hardy Nutritionals Daily Essential Nutrients.

Negative factors can include things like street drugs, prescription drugs so different from multiple classes and then the biological factors can be things like gut health, how healthy is the bowel, puberty, pregnancy, menstrual cycle, those are things that influence a person's experience with the nutrients and again these are just a few of the many factors that we've seen and again are kind of outlined in in section 8 of the Clinical Reference.

This short soundbite from one of our scientists explains how antibiotics may limit your success while using micronutrients.

When working with patients who are transitioning to Daily Essential Nutrients clinical broad-spectrum micronutrients, it is imperative that clinicians take time to review our Clinical Reference Guide.  We also recommend speaking with a member of our science team to ensure familiarity with medication-reduction protocols and best practices.

Dr. Brenda Leung, assistant professor at the University of Lethbridge's Faculty of Health Sciences is doing a first-of-its-kind study on ADHD in collaboration with colleagues at the University of Calvary, Oregon Health and Science University and The Ohio State University.

Prior to taking DEN I suffered with depression, post traumatic stress disorder and fatigue. I cried constantly. I felt despair.